UnitedHealth Group Signals Recovery with Q1 Earnings Beat and Raised Guidance

UnitedHealth Group (NYSE: UNH) has provided a strong signal of operational recovery in its first-quarter fiscal results, sparking an 8% rally in its share price. The results mark a potential turning point for the health insurer, which has struggled with significant underperformance over the past twelve months. The company reported first-quarter revenue of $111.7 billion, a slight increase from the $109.6 billion recorded in the same period last year. More importantly, adjusted earnings per share reached $7.23, comfortably beating the $6.57 consensus estimate and edging past the $7.20 reported in Q1 2025. A critical metric for the insurer, the medical benefits ratio—representing the portion of revenue passed to healthcare providers—fell to 83.9% from 84.8% a year ago. This figure came in significantly lower than the 85.6% analysts had anticipated, indicating that the company is successfully curbing the rising costs of medical coverage that previously weighed on the stock. Looking ahead, UnitedHealth raised its full-year adjusted earnings guidance to over $18.25 per share, surpassing the $17.86 estimate and the previous year's $16.35. This optimistic outlook is further bolstered by 2027 Medicare Advantage payment rates from the federal government that are more generous than previously forecasted. Under the renewed leadership of CEO Stephen Hemsley, the company appears to be stabilizing its margins. With a forward P/E ratio below 20 and a dividend yield of 2.7%, the stock is attracting renewed interest from value-oriented investors after a period of significant volatility.